Reporter brief
A Phase II Exploratory Clinical Study Investigating the Geroprotective Effect of Metformin in Middle-aged and Elderly People
What happened
Trial registry update: RECRUITING. No results reported in the supplied registry record.
Why it matters
Assessment pending; this report does not establish a change in evidence.
What it does NOT prove
- The abstract does not report actual results, outcomes, or effect sizes—it is only a research objective statement, so no efficacy claims can be evaluated
- Whether metformin produced any measurable effects on aging markers or whether any observed changes were clinically meaningful cannot be determined from the information provided
- The study design and any findings specific to particular age groups or sex cannot be assessed without results data
Study design and sample
Rct; Human.
Middle-aged and elderly males
- Design
- Rct
- Sample
- —
- Journal
- Xuanwu Hospital, Beijing
- Published
- Mar 21, 2025
Effect size
Not recorded.
Caveats
- Assessment: Unassessed.
- Only the source material recorded on this evidence page was assessed.
Conflicts and funding
Not recorded.
Previous evidence
See the Metformin timeline and recorded assessment for prior evidence.
Primary source
Cancel Death charts and briefs may be reproduced editorially with attribution to CancelDeath.com. This brief is generated from the primary recorded source facts and assessment. Its review status is shown below; verify quotations against the paper before publication.